Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study.

Wang, Victor S; Kosman, Justin; Yuan, Hsiangkuo; Lauritsen, Clinton; Shrewsbury, Stephen; Aurora, Sheena K; Hopkins, Mary; Silberstein, Stephen

Wang, Victor S; Kosman, Justin; Yuan, Hsiangkuo; Lauritsen, Clinton; Shrewsbury, Stephen; Aurora, Sheena K; Hopkins, Mary; Silberstein, Stephen.

Afiliación

Wang VS; Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Kosman J; Thomas Jefferson University College of Population Health, Philadelphia, Pennsylvania, USA.
Yuan H; Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Lauritsen C; Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Shrewsbury S; Impel Pharmaceuticals Inc., Seattle, Washington, USA.
Aurora SK; Impel Pharmaceuticals Inc., Seattle, Washington, USA.
Hopkins M; Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Silberstein S; Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Headache ; 63(9): 1251-1258, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37740562

Palabras clave

chronic daily headache; chronic migraine; dihydroergotamine; migraine; refractory headache

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: Headache Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google